PubRank
Search
About
J Oliver McIntyre
Author PubWeight™ 15.98
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Selective visualization of cyclooxygenase-2 in inflammation and cancer by targeted fluorescent imaging agents.
Cancer Res
2010
1.66
2
Imaging matrix metalloproteinases in cancer.
Cancer Metastasis Rev
2008
1.54
3
Optical imaging of matrix metalloproteinase-7 activity in vivo using a proteolytic nanobeacon.
Mol Imaging
2009
1.25
4
Noninvasive detection of matrix metalloproteinase activity in vivo using a novel magnetic resonance imaging contrast agent with a solubility switch.
Mol Imaging
2007
1.18
5
Increased diacylglycerols characterize hepatic lipid changes in progression of human nonalcoholic fatty liver disease; comparison to a murine model.
PLoS One
2011
1.08
6
Novel solubility-switchable MRI agent allows the noninvasive detection of matrix metalloproteinase-2 activity in vivo in a mouse model.
Magn Reson Med
2008
1.07
7
IL-13 and TH2 cytokine exposure triggers matrix metalloproteinase 7-mediated Fas ligand cleavage from bronchial epithelial cells.
J Allergy Clin Immunol
2010
0.93
8
New enzyme-activated solubility-switchable contrast agent for magnetic resonance imaging: from synthesis to in vivo imaging.
J Med Chem
2009
0.91
9
Establishment and quantitative imaging of a 3D lung organotypic model of mammary tumor outgrowth.
Clin Exp Metastasis
2008
0.88
10
Functional colonography of Min mice using dark lumen dynamic contrast-enhanced MRI.
Magn Reson Med
2008
0.86
11
Salivary proteinase activity: a potential biomarker for preterm premature rupture of the membranes.
Am J Obstet Gynecol
2006
0.83
12
Proteinase activity in human and murine saliva as a biomarker for proteinase inhibitor efficacy.
Clin Cancer Res
2004
0.82
13
Proliferative effects of apical, but not basal, matrix metalloproteinase-7 activity in polarized MDCK cells.
Exp Cell Res
2004
0.80
14
Synthesis and in vitro efficacy of MMP9-activated NanoDendrons.
Mol Pharm
2013
0.79
15
Utility of [18 F]FLT-PET to assess treatment response in trastuzumab-resistant and trastuzumab-sensitive HER2-overexpressing human breast cancer xenografts.
Mol Imaging Biol
2015
0.79
16
A novel in vitro assay to assess phosphorylation of 3'-[(18)F]fluoro-3'-deoxythymidine.
Mol Imaging Biol
2011
0.75